CDKN2A and neoplasm: Based on the analysis of 1061 pancreatic cancer samples from cBioPortal for Cancer Genomics, KRAS, TP53, SMAD4 and CDKN2A are the most common mutations in tumor-related genes, and all detected in over 10% patient samples.